## **Core Concept**
The question pertains to the side effects of various medications, specifically focusing on the risk of bleeding associated with certain drugs. This involves understanding the pharmacological properties of different classes of medications and their impact on coagulation and bleeding.

## **Why the Correct Answer is Right**
The correct answer, **D. Heparin**, is associated with a risk of bleeding due to its anticoagulant properties. Heparin works by enhancing the activity of antithrombin III, which inhibits thrombin and factor Xa, crucial steps in the coagulation cascade. This mechanism can lead to an increased risk of bleeding, especially if the dose is too high or if the patient has other risk factors for bleeding.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not specified, but if it refers to a medication not typically associated with bleeding as a primary side effect, it would be incorrect because it doesn't directly relate to the well-known risk of bleeding.
- **Option B:** Similarly, without specifics, if this option does not directly correlate with a high risk of bleeding as a known side effect, it would be incorrect.
- **Option C:** Again, lacking specifics, if this option does not represent a medication with a notable risk of bleeding, it would not be the correct answer.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that heparin-induced thrombocytopenia (HIT) is a serious side effect of heparin therapy, occurring in about 0.2-5% of patients. It paradoxically causes both thrombosis and bleeding due to the formation of antibodies against platelet factor 4-heparin complexes. Monitoring platelet counts is crucial during heparin therapy to detect HIT early.

## **Correct Answer: D. Heparin**